Imagenebio, Inc. Terminates and Extends Transition Services Agreement with Miragene Inc.

On October 23, 2025, Imagenebio, Inc. provided written notice to Miragene Inc. regarding the termination of the automatic renewal of their transition services agreement, which was originally dated July 25, 2025. Additionally, Imagenebio elected to extend the term for six months for a subset of the original services, including chemistry, manufacturing and controls, translational sciences research, and support. The total fees for these extended services amount to $200,000. This decision reflects Imagenebio's strategic adjustments in its ongoing business operations and collaborations.